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I N T R O D U C T I O N
During the last five years, since the advent of 64-slice multi-slice computed tom-
ography (MSCT) and thanks to the continuous technological improvements of this 
technique, the non-invasing imaging of the coronar y arteries has become much more 
reliable. Nowadays, MSCT coronary angiography (CTCA) enables visualization of 
not only the coronary artery stenoses and occlusions, but also of the atherosclerotic 
changes and plaques that are confined to the coronary vessel wall without causing 
significant stenoses.
Conventional selective X-ray coronary angiography (SCA) remains the undisputed 
standard of reference for the assessment of the lumen of coronary arteries. However, 
this is an invasive procedure with a small but not negligible health risk that needs even 
short hospitalization and causes patient discomfort. Among the more than 2.5 million 
examinations of SCA performed annually in U.S.A. and Europe, approximately 25% 
do not reveal essential findings and more than 40% are not followed by any kind of 
interventional or surgical procedure.1 On the other hand, SCA does not provide any 
information concerning the coronary wall, while almost 80% of deadly myocardial 
infarctions are attributed to vulnerable plaques which did not cause hemodynamically 
severe stenoses.2 Myocardial perfusion imaging (MPI) with single-photon emission 
computed tomography (SPECT) is a well-established and clinically useful technique 
for the detection of coronary artery disease (CAD), but its results can be normal in 
cases of non-significant (<50%) coronary artery stenoses and even in cases of high-
risk CAD (left main and balanced 3-vessel CAD).
M S C T :  T E C H N I C A L  I S S U E S
MSCT coronary angiography is performed during a single breath-hold and the 
coronary lumen is opacified by a very fast (bolus) intravenous injection of an iodin-
ated contrast medium (80-100 ml are generally sufficient with the latest technology 
scanners), followed by a flush bolus of 100 ml of normal saline. ECG is simultaneously 
recorded during data acquisition, allowing retrospective gating and slice reconstruc-
tion at the most appropriate position within the cardiac cycle; this is, typically, the 
mid-to-end diastolic period, in order to minimize motion artifacts, but it may vary 
for each coronary branch (particularly at faster heart rates).4 MSCT scanners have an 
inherently limited temporal resolution (the time needed for data collection per cardiac 
cycle), which cannot be better than 165 ms with the 64-slice technology and, in general, 
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with any scanner that uses a single X-ray tube. At high heart 
rates, motion artifacts are often observed and degrade the 
image quality. This problem can be managed by the use of oral 
or intravenous (IV) β-receptor blocking agents. A heart rate 
between 50 and 60 beats per minute (bpm) is considered to be 
ideal and, if it remains during the data acquisition, significantly 
increases the number of assessable coronary segments. Also, 
sublingual administration of nitrates, just a few minutes before 
the CT coronary angiography (CTCA), was found to result in 
significantly larger proximal coronary diameters and is now 
widely recommended for routine examinations.
The evolution from 4-slice to 64-slice technology permit-
ted significant decrease of the breath-hold duration (from 
35-40 sec to 5-12 sec) and of the amount of iodinated contrast 
medium needed (from 180 to 80-100 ml). Also, the spatial 
resolution improved. The direct benefit was the significant 
improvement of the proportion of the evaluable coronary 
segments (approximately from 70% to 95%). Additionally, a 
significant improvement of all the parameters of diagnostic 
performance of CTCA, both at patient and coronary segment 
level, was validated.4-10
C T C A :  D I A G N O S T I C  P E R F O R M A N C E
There are cumulative data from the literature, providing 
validation of CTCA in comparison to SCA, for detecting 
significant coronary artery stenoses. All the studies reported 
a very high negative predictive value (NPV) as a major 
strength of this modality. Many studies, comparing 64-slice 
CTCA with SCA in patients with suspected CAD, showed, at 
coronary segment level, sensitivity of 88-97% (average 93%), 
specificity of 96-97% (average 96%), positive predictive value 
(PPV) of 66-87% and an excellent NPV of 99% for detecting 
stenoses >50% at coronary segments with a lumen diameter 
>1.5 mm. About 85-100% of all coronary segments could be 
evaluated with CTCA, depending on the selection criteria 
of the population of each study. At patient-based detection, 
sensitivity and specificity were up to100%. However, high-
performance results achieved at academic sites with high 
expertise are probably not reproducible at a wider practice of 
CTCA. Additionally, the results are influenced by the patient 
selection criteria.9-16
The technology of dual-source 64-slice MSCT is already 
widely available and established new milestones in non-inva-
sive coronary imaging. By using two coupled X-ray tubes, it 
became possible to achieve a true temporal resolution of 83 
ms, thus permitting reliable visualization of the distal coronary 
arteries even with high heart rate and, in most cases, obviating 
the need for β-blockers. Examinations of good to excellent 
quality, even in cases of arrhythmia or atrial fibrillation, are 
now routinely acquired with that new technology. Addition-
ally, a significant decrease of the mean radiation dose seems 
to be achievable.17,18
C T C A :  I N D I C A T I O N S  ( T A B L E  1)
Evolving and proposed indications for the clinical use of 
CTCA include:19,20
 a. detection of congenital anomalies of the coronary arter-
ies; however, this goal can be reliably accomplished with 
MRI, obviating the need for iodinated contrast medium 
and without exposure to ionizing radiation.
 b. exclusion of coronary artery disease (CAD) in individuals 
with low-to-moderate pretest probability: asymptomatic 
high-risk, patients with atypical chest pain and/or equivo-
cal stress-test results. According to the recent guidelines 
of the American Heart Association (AHA) and European 
Society of Cardiology (ESC), the potential benefit from 
the use of CTCA is greater in symptomatic patients with 
intermediate clinical risk for CAD (category IIa-B test, ac-
cording to AHA guidelines).21,22 Some recently published 
studies concluded to similar recommendations.23-25
 c. patients with a SCA that was incomplete or failed to visual-
ize a major coronary branch or posed the suspicion of left 
main coronary artery stenosis.
 d. evaluation of by-pass grafts: CTCA is highly accurate 
in confirming patency or occlusion, but its accuracy for 
evaluating the degree of graft stenosis has not been well 
established yet. Since the advent of 64-slice scanners, 
it seems reliable to assess graft stenosis, patency of the 
anastomosis with the indigenous artery and visualization 
TABLE 1. Indications for the clinical use of computed 
tomography coronary angiography
● detection of congenital anomalies of the coronary arteries 
(however, this can be reliably accomplished with MRI, obviating 
the need for contrast medium and exposure to ionizing 
radiation)
● exclusion of coronary artery disease in individuals with low-to-
moderate pretest probability
● incomplete or failed visualization by SCA of a major coronary 
branch or suspicion posed by SCA of left main coronary artery 
stenosis
● evaluation of coronary by-pass grafts
● evaluation of coronary arteries in patients scheduled to undergo 
non-coronary cardiovascular surgery, such as valve replacement 
and aortic aneurysm repair
● patients with atrial fibrillation, prior to administration of anti-
arrhythmic drugs and catheter ablation
● to assess (with a single examination) for coronary artery disease, 
aortic dissection or rupture, and pulmonary embolism (“triple rule-
out”) in patients presenting with acute chest pain in the emergency 
department, without specific ECG-changes and normal cardiac 
enzymes
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of the lumen of the more distal coronary segments.26
 e. evaluation of the coronary arteries in patients scheduled 
to undergo non-coronary cardiovascular surgery, such as 
valve replacement and aortic aneurysm repair.27
 f. patients with atrial fibrillation, prior to administration of 
anti-arrhythmic drugs and catheter ablation.
 h. patients presenting with acute chest pain in the emergency 
department, without specific ECG-changes and normal 
counts of cardiac enzymes: CTCA can be used effectively 
for detecting or excluding (with a single examination) 
CAD, aortic dissection or rupture and pulmonary embo-
lism (“triple rule-out”).28-30
The diagnostic accuracy and subsequent clinical useful-
ness of CTCA are dependent on the risk profile for CAD of 
the patient population. It should be noted that CTCA has not 
yet proven to be suitable for evaluating patients with already 
known or very probable CAD, since its accuracy for grading 
the degree of lumen stenosis -especially from heavily calcified 
plaques- is not yet established.31
C T C A :  L I M I T A T I O N S
CTCA may be impaired from artifacts caused by dense 
calcifications and other hyperdense structures, such as surgi-
cal clips, sternal sutures and stents. Practically, patients with 
a high calcium score cannot be reliably evaluated by CTCA. 
Heavily calcified plaques, especially those with a concentric 
pattern, are accompanied by the “blooming artifact” which 
often precludes accurate evaluation of the degree of lumen 
stenosis, usually leading to overestimation.12,32 Obese patients 
can now be examined more reliably, by using the 64-slice 
or newer technology, even accepting the lower image qual-
ity and at the expense of higher radiation dose. The lumen 
within coronary stents cannot be routinely well visualized, but 
patency of the stented segment can usually be assessed. The 
assessability of a stent depends on its particular structure and 
size and varies significantly among the different stent types. 
Some recent studies using the 64-slice or newer technology 
showed very promising results for assessing in-stent restenosis, 
but broader studies are needed to validate this reported high 
diagnostic performance.33,34
The need for intravenous injection of a significant quantity 
of iodinated contrast medium and the exposure to radiation 
are the main disadvantages of CT, compared to magnetic 
resonance imaging (MRI), and preclude its use in patients 
with renal insufficiency or allergy to iodine and in pregnant 
women. However, the image quality of a non-invasive coronary 
angiography (in terms of spatial resolution and contrast-to-
noise ratio) using CT, is by far better compared to MRI.
The issue of radiation exposure has to be seriously consid-
ered, especially when the possible role of CTCA as a screening 
tool in high-risk asymptomatic patients is discussed. Using 
state-of-the-art 64-slice scanners, the effective radiation dose 
during CTCA was measured equal to 10-15 mSv in men and 
14-21.4 mSv in women.9-13 This is higher of the average dose 
of diagnostic SCA (up to 11.4 mSv) and comparable to that of 
thallium or technetium myocardial scintigraphy (8-18 mSv). 
However, recent data and our initial personal experience by 
using dual-source 64-slice CTCA with ECG-tube modulation 
(which reduces the X-ray tube current and, consequently, the 
radiation exposure during the part of the cardiac cycle where 
data are not selected) show a significant decrease of the aver-
age radiation dose.35 In any case, CTCA should be avoided in 
young patients and, especially, young women.
C T C A :  E VA L U A T I O N  O F  C O R O N A R Y  WA L L  A N D 
P L A Q U E  S T R U C T U R E
Besides of evaluating the coronary lumen, CTCA is cur-
rently the only available tool for non-invasive assessment of the 
coronary vessel wall. By using 64-slice and newer technology, 
the coronary plaques can now be reliably detected and clas-
sified, according to their density, into calcified, non-calcified 
(soft) and mixed. Exact localization and estimation of the 
total atherosclerotic plaque burden (plaque volumetry) and, 
also, detection of the positive or negative remodeling of the 
coronary vessel wall, are now feasible. Several studies have 
shown moderately good correlation of MSCT findings with 
those of intravascular ultrasound. The capability of accurate 
and reproducible plaque volumetry could be used in monitor-
ing the therapeutic result of lipid lowering therapy. However, 
current resolution of CTCA does not allow detection of certain 
characteristics of the vulnerable plaque, such as a thin fibrous 
cap, a lipid core or inflammation.36-38
C T C A :  P R O G N O S T I C  VA L U E
During the last 3 years, cumulative data from several 
studies confirm the independent prognostic information, over 
conventional clinical risk factors, that multislice CTCA can 
provide in patients with known or suspected CAD. An excel-
lent prognosis was noted in patients with a normal CTCA, 
a result that underscores the excellent NPV of this test for 
excluding the presence of CAD. Additionally, an elevated 
rate of “coronary events” -like nonfatal myocardial infarct, 
unstable angina requiring hospitalization, revascularization 
or even death due to acute myocardial infarct- was reported in 
patients with nonobstructive or non significant CAD (lumen 
stenosis between 25-75%), even in medium-term follow-up 
periods of 16 to 72 months. Other studies showed that CTCA 
is an independent predictor of coronary events and provides 
incremental prognostic value to myocardial perfusion imaging 
with SPECT.39-44
M S C T :  O T H E R  I N F O R M A T I O N
Beyond the visualization of coronary arteries, the same 
data set that is acquired during CTCA, also contains valuable 
information that can be used for assessment of the morphol-
ogy and function of cardiac ventricles, with accuracy similar 
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to that of MRI, morphological and functional evaluation of 
cardiac valves, with results comparable to echocardiography, 
and estimation of myocardial viability, with an accuracy com-
parable to that of MRI.45-49
M S C T :  F U T U R E  P E R S P E C T I V E
Awaiting for the results of large studies using the dual-
source 64-slice technology, the first 256, 320 and even 420-
slices single-source scanners, allowing examination of the en-
tire heart during one heartbeat, are already available in a few, 
mostly academic, sites. However, as single source scanners, 
they are still hampered by suboptimal temporal resolution 
(>120 ms). In parallel, recent technological advances made 
the dual-source technology even more robust and efficient. At 
the same time, the intense effort of all MSCT system vendors 
for reducing the radiation dose, has reached a point where 
examination doses as low as 1 mSv seem to be feasible.
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